tirzepatide weight loss outcomes How Helped A 24 Year Old Lose 60 Pounds In 11 Months Tirzepatide (Mounjaro/Zepbound) weight loss results!
Description
Both are approved for weight management in adults with obesity or overweight plus a related health condition
The US Food and Drug Administration approved the medication Zepbound last week to treat chronic obesity
This might include eating on a schedule rather than waiting for hunger cues, since GLP-1 therapy specifically blunts those cues
Before increasing tirzepatide dosage, several safety assessments are essential
This conclusion is based on studies where laboratory animals given semaglutide, liraglutide, tirzepatide and other GLP-1 medications developed tumors
